Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 18 analysts

Viridian Therapeutics Inc has a share price target of US$ 42, revenue growth forecast of 28726.7%, and profit growth estimate of -18.6% for FY25, based on top 18 analyst calls.